AmeriHealth® RxPennsylvania and West VirginiaAmeriHealth Rx is a Medicare-approved prescription drug plan (PDP). offered by QCC Insurance Company. AmeriHealth Rx is administered by FutureScripts Secure, a pharmacy benefit management program, and available throughout Pennsylvania and West Virginia. With AmeriHealth Rx, you have a choice of the following benefit options: Option IMonthly Premium: $39.80Option I provides the standard Medicare Part D prescription drug benefit (with $275 annual deductible; 25% coinsurance from $276 to $2,510 in total yearly costs). After the member’s yearly out-of-pocket costs reach $4.050 TrOOP, AmeriHealth Rx members will pay the greater of 5% coinsurance or $2.25 generic and $5.60 brand copay thereafter. Option IIMonthly Premium: $51.50Option II provides a higher level of coverage than Option I. There is no deductible. Before the total yearly drug costs (paid by the member and/or plan) reach $2,350, AmeriHealth Rx members will pay the following for prescription drugs:
You pay 100% of drug costs at discounted prices through the coverage gap. After total-out-of-pocket drug costs reach $4,050, AmeriHealth Rx members will pay the greater of 5% coinsurance or $2.25 generic and $5.60 brand copay thereafter. AmeriHealth Rx Plan Option Comparison Chart:
DefinitionsPremiums Deductible Coinsurance Coverage Gap If you have limited income and resources, you may qualify for low-income subsidy. When you join AmeriHealth Rx, Medicare will tell us how much extra help you are getting. Then, we will let you know the amount you will pay. If you qualify, your drug costs will also be lower. You can see if you qualify for a low-income subsidy by calling:
Please note: In some cases, Medical Assistance copays will apply. Benefits listed here are effective January 1, 2008. Benefits, formulary, pharmacy and provider networks, premiums, and/or copays may change on January 1, 2009. AmeriHealth Rx prospective members should call 1-800-898-3492 (TTY/TDD: 1-877-219-5457), seven days a week, 8 a.m. to 8 p.m., for questions related to the product. Best Available Evidence PolicyEarly in 2006, a number of factors contributed to the problem of incorrect cost-sharing levels for full-benefit dual eligible’s and other LIS eligible individuals. The purpose of this link is to provide a member with information on CMS best available data policy. In certain cases, CMS systems do not reflect a beneficiary’s correct low-income subsidy (LIS) status at a particular point in time. To address these situations, CMS created the best available evidence (BAE) policy. This policy requires Plans to establish the appropriate cost-sharing for low-income beneficiaries when presented with evidence that the beneficiary’s information is not accurate. Learn more about the Best Available Evidence Policy. |